论文部分内容阅读
目的:提高我国疫苗上市后安全监测的能力,明确我国疫苗上市后监测未来发展的方向。方法:介绍世界卫生组织《全球疫苗安全蓝图》出台的背景、战略目标与执行目标,分析我国疫苗上市后安全监测现状。结果与结论:近年来,我国疫苗上市后安全性监测发展迅速,取得的成绩也得到了国际的认可。但与《全球疫苗安全蓝图》提出的目标相比,我们在主动监测、信号分析、数据规范等方面仍存在不足。可以借助世界卫生组织和其他国际组织的力量,推动我国疫苗上市后监测迈上新的台阶。
OBJECTIVE: To improve the ability of our country to monitor the safety of the vaccine after its listing, and to clarify the direction of the future development of the vaccine after its listing in China. Methods: Introducing the background, strategic goals and implementation targets of World Health Organization “Global Vaccine Safety Blueprint”, and analyzing the status of safety monitoring after the listing of vaccines in China. RESULTS AND CONCLUSION: In recent years, the safety monitoring of vaccines in our country has been developed rapidly, and the achievements made have been internationally recognized. However, compared with the goals outlined in the “Global Vaccine Safety Blueprint,” we still have some deficiencies in active monitoring, signal analysis and data specification. With the help of the World Health Organization and other international organizations, we can push the post-mar- ket monitoring in China to a new level.